Two Sigma Investments, LP Decibel Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.85 - $4.21 $41,269 - $93,916	-22,308 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.83 - $5.03 $70,919 - $126,051	-25,060 Reduced 52.9%	22,308 $68,000
Q4 2021 Feb 14, 2022	BUY	$4.57 - $8.58 $216,471 - $406,417	47,368 New	47,368 $220,000
Q3 2021 Nov 15, 2021	SELL	$6.6 - $9.04 $224,406 - $307,369	-34,001 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.39 - $11.51 $110,662 - $199,330	-17,318 Reduced 33.75%	34,001 $292,000
Q1 2021 May 17, 2021	BUY	$10.56 - $19.9 $541,928 - $1.02 Million	51,319 New	51,319 $583,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.